华恒生物2025年一季报简析：增收不增利，公司应收账款体量较大

证券之星2025-04-24

据证券之星公开数据整理，近期华恒生物(688639)发布2025年一季报。截至本报告期末，公司营业总收入6.87亿元，同比上升37.2%，归母净利润5109.61万元，同比下降40.98%。按单季度数据看，第一季度营业总收入6.87亿元，同比上升37.2%，第一季度归母净利润5109.61万元，同比下降40.98%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529166717?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-24 06:10","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529166717","market":"sh","top_or_hot":-1,"title":"华恒生物2025年一季报简析：增收不增利，公司应收账款体量较大","media":"证券之星","content":"<div>\n<p>据证券之星公开数据整理，近期华恒生物(688639)发布2025年一季报。截至本报告期末，公司营业总收入6.87亿元，同比上升37.2%，归母净利润5109.61万元，同比下降40.98%。按单季度数据看，第一季度营业总收入6.87亿元，同比上升37.2%，第一季度归母净利润5109.61万元，同比下降40.98%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424061540a6c5b1c4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华恒生物2025年一季报简析：增收不增利，公司应收账款体量较大</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华恒生物2025年一季报简析：增收不增利，公司应收账款体量较大\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-24 06:10 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424061540a6c5b1c4&s=b><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>据证券之星公开数据整理，近期华恒生物(688639)发布2025年一季报。截至本报告期末，公司营业总收入6.87亿元，同比上升37.2%，归母净利润5109.61万元，同比下降40.98%。按单季度数据看，第一季度营业总收入6.87亿元，同比上升37.2%，第一季度归母净利润5109.61万元，同比下降40.98%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424061540a6c5b1c4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688639","symbol_name":"华恒生物","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424061540a6c5b1c4&s=b","article_id":"2529166717","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424061540a6c5b1c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529166717","pubTimestamp":1745446238,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"据证券之星公开数据整理，近期华恒生物发布2025年一季报。截至本报告期末，公司营业总收入6.87亿元，同比上升37.2%，归母净利润5109.61万元，同比下降40.98%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达162.45%。去年的净利率为8.47%，算上全部成本后，公司产品或服务的附加值一般。持有华恒生物最多的基金为交银先进制造混合A，目前规模为43.06亿元，最新净值3.7851，较上一交易日上涨0.2%，近一年上涨13.33%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688639":"华恒生物","BK0229":"化学制品"},"translate_title":"Brief analysis of Huaheng Biotech's 2025 first quarter report: Increase revenue but not increase profits, and the company's accounts receivable are relatively large","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688639":1},"content_text":"据证券之星公开数据整理，近期华恒生物(688639)发布2025年一季报。截至本报告期末，公司营业总收入6.87亿元，同比上升37.2%，归母净利润5109.61万元，同比下降40.98%。按单季度数据看，第一季度营业总收入6.87亿元，同比上升37.2%，第一季度归母净利润5109.61万元，同比下降40.98%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达162.45%。本次财报公布的各项数据指标表现一般。其中，毛利率24.31%，同比减27.6%，净利率7.15%，同比减58.29%，销售费用、管理费用、财务费用总计7536.37万元，三费占营收比10.97%，同比增14.85%，每股净资产10.48元，同比减13.29%，每股经营性现金流0.06元，同比增109.59%，每股收益0.2元，同比减42.86%证券之星价投圈财报分析工具显示：业务评价：公司去年的ROIC为6.08%，资本回报率一般。去年的净利率为8.47%，算上全部成本后，公司产品或服务的附加值一般。融资分红：公司上市4年以来，累计融资总额13.25亿元，累计分红总额3.36亿元，分红融资比为0.25。商业模式：公司业绩主要依靠资本开支及股权融资驱动，还需重点关注公司资本开支项目是否划算以及资本支出是否刚性面临资金压力。需要仔细研究这类驱动力背后的实际情况。财报体检工具显示：建议关注公司现金流状况(货币资金/流动负债仅为51.26%)建议关注公司债务状况(有息资产负债率已达31.63%)建议关注公司应收账款状况(应收账款/利润已达162.45%)分析师工具显示：证券研究员普遍预期2025年业绩在2.94亿元，每股收益均值在1.18元。持有华恒生物最多的基金为交银先进制造混合A，目前规模为43.06亿元，最新净值3.7851(4月23日)，较上一交易日上涨0.2%，近一年上涨13.33%。该基金现任基金经理为刘鹏。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529166717","isCrawlerRequest":true}